METHODS OF MODULATING THE ACTIVITY OF THE MC1 RECEPTOR AND TREATMENT OF CONDITIONS RELATED TO THIS RECEPTOR
申请人:Mimetica Pty Ltd
公开号:US20140128380A1
公开(公告)日:2014-05-08
The present invention provides compounds of Formula (I) that are useful for binding and/or modulating the biological activity of the melanocortin-1 receptor (MC1R). Compounds of this invention can be used to treat diseases and/or conditions in which modulation of MC1R is beneficial. Such diseases and/or conditions include, but are not limited to, hyperpigmentation (including melasma), hypopigmentation (including vitiligo), melanoma, basal cell carcinoma, squamous cell carcinoma, erythropoietic protoporphyria, polymorphous light eruption, solar urticaria, photosensitivity, sunburn, inflammatory diseases, aberrant fibroblast activity and pain.
本发明提供了式(I)的化合物,它们对结合和/或调节黑素细胞激素-1受体(MC1R)的生物活性是有用的。本发明的化合物可用于治疗调节MC1R有益的疾病和/或病况。这些疾病和/或病况包括但不限于色素沉着症(包括黄褐斑),色素减退症(包括白癜风),黑色素瘤,基底细胞癌,鳞状细胞癌,红细胞生成性卟啉症,多形性光敏性皮疹,太阳性荨麻疹,光敏性,晒伤,炎症性疾病,异常成纤维细胞活性和疼痛。